FDA Grants Orphan Drug Designation to Onspira Therapeutics’ Investigational Interleukin-1 Receptor Antagonist for the Treatment of Bronchiolitis Obliterans
<a href="https://pixabay.com/users/InspiredImages/">InspiredImages</a> / Pixabay

FDA Grants Orphan Drug Designation to Onspira Therapeutics’ Investigational Interleukin-1 Receptor Antagonist for the Treatment of Bronchiolitis Obliterans

According to a story from Business Wire, the biopharmaceutical company Onspira Therapeutics recently announced that its investigational therapy OSP-101 was recently granted Orphan Drug designation by the US Food and…

Continue Reading
Is There a Genetic Condition in Your Family?
<a href="https://pixabay.com/users/Thor_Deichmann/">Thor_Deichmann</a> / Pixabay

Is There a Genetic Condition in Your Family?

Is there a genetic condition in your family? Are you concerned about the potential for passing this on to your children one day? Do you know if you are a…

Continue Reading
Close Menu